31 – 40 of 214
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease – Results from two independent population-based cohorts and a meta-analysis
(
- Contribution to journal › Article
-
Mark
Large-Scale Metabolomics and the Incidence of Cardiovascular Disease
(
- Contribution to journal › Article
-
Mark
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.
(
- Contribution to journal › Article
-
Mark
Polygenic risk in Type III hyperlipidaemia and risk of cardiovascular disease : An epidemiological study in UK Biobank and Oxford Biobank
(
- Contribution to journal › Article
-
Mark
Red cell distribution width and its polygenic score in relation to mortality and cardiometabolic outcomes
(
- Contribution to journal › Article
- 2022
-
Mark
Insulin, Glucose, and the Metabolic Syndrome in Cardiovascular Behavioral Medicine
2022) p.809-831(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort
(
- Contribution to journal › Article
-
Mark
Estimating the Direct Effect between Dietary Macronutrients and Cardiometabolic Disease, Accounting for Mediation by Adiposity and Physical Activity
(
- Contribution to journal › Article
-
Mark
Comorbidities in hereditary angioedema—A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Air pollution and biomarkers of cardiovascular disease and inflammation in the Malmö Diet and Cancer cohort
(
- Contribution to journal › Article